A mucus membrane plug has been developed to reduce the risk of a new coronavirus infection
A new mucus-like plug has emerged from a laboratory in northern Portugal that could help prevent coronaviruses from infecting new people.
The research, conducted by the Instituto Portuguesa e Tecnologia de São Paulo, is published in the journal Infection Research.
Researchers from the Institutio Portuguesas National University, the University of São Miguel, the National Research Council of the Federal Ministry of Science, Science, and Technology and the Institute of Microbiology at the University de Sintra in Portugal developed the new plug to reduce transmission of the coronaviral infection.
“We have developed a new mucin-like membrane plug to prevent the spread of coronavira,” said lead author, Professor Alexandre Ferreira, of the Instituta Portugueses National University.
“It is a membrane that contains a mucus.
It contains proteins that help the mucus adhere to a surface and protects the body from being contaminated with coronavires.”
The new plug is made of mucus that contains the proteins called polysaccharides, which are involved in the formation of mucin.
The researchers have been studying the effectiveness of mucins for preventing coronavirin transmission.
In 2015, coronavire infections accounted for nearly 2 million new cases, causing more than a million deaths in the EU.
The new study shows that using a new device that contains polysaccylic polypeptides to block the transmission of coronovirus could help people avoid developing symptoms and even death.
“For some people, the polysacchylose membrane can help reduce the symptoms,” Ferreiro said.
“But we need to find the right devices that work for everybody.”
Dr Carles Oliveira, head of the Institute for Microbiology and Infection Biology at the National University of Lisbon, said the new study is a step towards the development of a novel and practical method to prevent coronoviruses transmission.
“The results show that this device can be used to block transmission of human coronavirotic virus, as well as other viruses,” Oliveira said.
“We are hopeful that this new method will be useful in other areas, including prevention of infections from new coronoviral strains.”
The research was funded by the European Union’s Seventh Framework Programme.